{"url_path":"/register/2026-07-06/2026-13492","section_key":"summary","section_title":"Determination That VASOPRESSIN IN SODIUM CHLORIDE (vasopressin) 0.9%, Injection, 50 units/50 milliliters (1 unit/milliliters) Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness","topic":"register","document":{"doc_type":"Notice","doc_date":"2026-07-06","source_url":"https://www.federalregister.gov/documents/2026/07/06/2026-13492/determination-that-vasopressin-in-sodium-chloride-vasopressin-09-injection-50-units50-milliliters-1","accession_number":null,"cik":null,"ticker":null,"issuer_name":null,"edgar_url":null,"primary_entity_key":null,"primary_entity_name":"Health and Human Services Department"},"word_count":112,"has_tables":false,"body_markdown":"# Determination That VASOPRESSIN IN SODIUM CHLORIDE (vasopressin) 0.9%, Injection, 50 units/50 milliliters (1 unit/milliliters) Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness\n\n**Type:** Notice\n**Published:** 2026-07-06\n**Citation:** 91 FR 41041\n**Agencies:** Health and Human Services Department, Food and Drug Administration\n**Source:** https://www.federalregister.gov/documents/2026/07/06/2026-13492/determination-that-vasopressin-in-sodium-chloride-vasopressin-09-injection-50-units50-milliliters-1\n\n## Abstract\nThe Food and Drug Administration (FDA or Agency) has determined that VASOPRESSIN IN SODIUM CHLORIDE (vasopressin) 0.9%, injection, 50 units/50 milliliters (mL) (1 unit/mL) was not withdrawn from sale for reasons of safety or effectiveness. This determination will allow FDA to approve abbreviated new drug applications (ANDAs) for VASOPRESSIN IN SODIUM CHLORIDE (vasopressin) 0.9%, injection, 50 units/ 50 mL (1 unit/mL), if all other legal and regulatory requirements are met."}